FIELD: biochemistry.
SUBSTANCE: described is a lipopolysaccharide, endotoxins antagonist, produced strain Rhodobacter capsulatus PG, which are deposited in RAS IBFM under number B-2381 D, as an agent for monocyte-like cell differentiation. Presented lipopolysaccharide Rhodobacter capsulatus PG is physiological, practically nontoxic. Invention can be used as an agent for monocyte-like cell differentiation.
EFFECT: proposed device can be used for preparing cardiologic drugs, particularly to oncology.
1 cl, 3 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF PHOTOTROPHIC BACTERIA RHODOBACTER CAPSULATUS PG LIPOPOLISACCHARIDE AS FACTOR AFFECTING DIFFERENTIATION ACTIVITY OF 1ALFA,25-DIHYDROXYVITAMIN D3 | 2016 |
|
RU2642309C1 |
| ANTI-ALLERGIC AGENTS | 2017 |
|
RU2690430C2 |
| METHOD FOR IDENTIFYING FUNCTIONAL M1 AND M2 PHENOTYPE OF HUMAN MACROPHAGES GENERATED IN VITRO FROM BLOOD MONOCYTES | 2019 |
|
RU2717024C1 |
| MEANS FOR BLOCKING THE EFFECTS OF LIPOTEICHOIC ACIDS - TOLL-LIKE RECEPTOR 2 AGONISTS | 2022 |
|
RU2781012C1 |
| METHOD OF ENHANCEMENT OF IMMUNE RESPONSE TO ANTIGENE IN MAMMALS | 2004 |
|
RU2341289C2 |
| STRAIN OF RHODOBACTER CAPSULATUS PG - PRODUCER OF LIPOPOLYSSACHARIDE, ENDOTOXIN ANTAGONIST | 2008 |
|
RU2392309C1 |
| HORMONE D (VITAMIN D) AND ITS DERIVATIVES FOR THE TREATMENT AND PREVENTION OF CANCER | 2019 |
|
RU2794340C1 |
| METHOD OF MODIFICATION OF PERIPHERAL BLOOD MONOCYTES TO INCREASE THEIR PARACRINE ACTIVITY DURING AUTOLOGOUS TRANSPLANTATION | 2012 |
|
RU2497947C1 |
| USE OF BIOMARKERS TO ASSESS EFFECTIVENESS OF COMPOSITION IN REDUCING EFFECT OF ANTI-CANCER THERAPEUTIC AGENTS ON SKIN | 2020 |
|
RU2836055C1 |
| METHOD OF PREDICTING EFFECTOR FAILURE OF CYTOTOXIC CELLS BY INCREASING CONCENTRATIONS OF SCD54, SCD56, SCD71 MOLECULES IN THE BLOOD | 2023 |
|
RU2811001C1 |
